好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Neurology Digital 好色先生 Scholars Program: Year One Outcomes
好色先生, Research, and Methodology
P12 - Poster Session 12 (11:45 AM-12:45 PM)
5-024
To report the one-year outcomes of the inaugural Neurology Digital 好色先生 Scholars Program (NDESP).

The NDESP is a longitudinal, nationally available, virtual educator skill development program that teaches neurologists evidence-based practices for creating and incorporating digital education into teaching, career development, and lifelong learning. The NDESP is supported by the Neurology Digital 好色先生 Collaborative (NDEC), a growing group of 23 medical educators focused on empowering neurologists to incorporate evidence-based digital education into teaching practices. The NDESP curriculum includes 12 courses over 10 months dedicated to (1) digital education and (2) educator development. 
Program evaluations completed by scholars contain self-reported domains collected through REDCap.  After the program, scholars are asked to self-report their satisfaction and retrospective comfort with digital education before and after the program and self-identified digital education scholar skill level.
The first two cohorts (Table 1) had varying demographics and backgrounds and were recruited through word-of-mouth/colleagues or Twitter/X. Most participants did not have prior digital education training. The first NDESP class completed the program in June 2024, with 12/22 (55%) completing all required elements to earn a certificate. Of those, most reported growth in professional educator identity (8/12, 67%), felt the NDESP met or exceeded their learner goals (12/12, 100%), and joined the NDEC as faculty and committee members (10/12, 83%). Participants preferred the live format (7/12, 58%), reporting it provided more value (10/12, 83%) than on-demand sessions. The most significant participation barriers were time (9/12, 75%) and lack of knowledge/confidence (2/12, 17%). The curriculum, survey, and time burden were adapted based on feedback.
The NDESP was feasible and had a positive impact on participants. The program supports a growing community of neurology educators.
Authors/Disclosures
Jessica H. Goldstein, MD, FAAN
PRESENTER 		Dr. Goldstein has nothing to disclose.
Natalie Erickson Miss Erickson has nothing to disclose.
Abhilash Velaga, MBBS Mr. Velaga has nothing to disclose.
Avin Aphrodite Babakhani, MD, PhD Dr. Babakhani has nothing to disclose.
Jeffrey Strelzik, MD Dr. Strelzik has nothing to disclose.
Casey S. Albin, MD, FAAN (Emory Healthcare) Dr. Albin has received personal compensation in the range of $0-$499 for serving as a Consultant for Azurity Pharmaceutical. Dr. Albin has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum: Life Long Learning in Neurology. Dr. Albin has received research support from 好色先生. Dr. Albin has received publishing royalties from a publication relating to health care.
Alison L. Christy, MD, PhD, FAAN Dr. Christy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity. Dr. Christy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishing. Dr. Christy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDLinx. The institution of Dr. Christy has received research support from Biohaven. The institution of Dr. Christy has received research support from Novartis / Amgen. The institution of Dr. Christy has received research support from Eli Lilly. The institution of Dr. Christy has received research support from Abbvie.
Rohit A. Marawar, MD, FAAN (Wayne State University - Detroit Medical Center) Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Kathryn L. Xixis, MD Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a Neurology Committee Member to ACGME-ABMS Symposium on CBME (hotel and travel expenses) with ACGME. Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a Child Neurology Representative to ABPN Critical Issues Forum (on CBME) (hotel and travel expenses) with ABPN. Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker (Honorarium) with Oklahoma State Graduate Medical 好色先生 Committee. Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a AAN 好色先生 Committee Member (hotel and travel expenses) with AAN. Dr. Xixis has received personal compensation in the range of $500-$4,999 for serving as a UCNS Accreditation Council (hotel and travel expenses) with UCNS. Dr. Xixis has a non-compensated relationship as a Podcast Writer and Editor of CNS Podcast Brainstorm with Child Neurology Society that is relevant to AAN interests or activities.
Jaclyn Martindale, DO, FAAN (Wake Forest Medical Center) Dr. Martindale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Dr. Martindale has received research support from Tourette Association of America. The institution of Dr. Martindale has received research support from American Board of Neurology and Psychiatry.